Chapter XVI

The newspapers Saturday morning gave full play to the Thurman disappearance. Several of them ran biographies of the missing senator, tracing his political career from the early founding days of the National-Liberal Party to his present anti-reanimation stand.

The police and FBI statements were simply mechanical handouts, repeats of last night’s assurances that no stone would be left unturned. Harker read them with some amusement. He had slept well, and a good deal of last night’s tension had departed from him.

He had come to a calming conclusion: Raymond and Barchet had done a violent thing, but these were violent times. Somehow he would have to forget about the shocking Thurman affair and continue along the path already entered upon.

The obituary pages contained one item worth note:

SIMEON BARCHET

Simeon Barchet of 210 Princeton Road, Rockville Centre, L.I., treasurer of the Better Research Laboratories, died of a heart attack at the Better office in Litchfield, New Jersey yesterday. His age was 61.

Mr. Barchet joined the organization of the late oil operator D. F. Better in 2014, after serving as a vice-president of the Chase Manhattan Bank. Upon Mr. Belter’s death ten years later, he became a trustee of the Better Fund and participated actively in the operation of the laboratory in Litchfield.

He left no survivors. His wife, the former Elsie Tyler, died in 2029.

Harker felt inward relief. Raymond had not dared to defy him; the reanimation of Barchet had been stopped as he had ordered.

It was only to be expected that some keen-eyed reader would read the Barchet obit and wonder why an official of the Seller Laboratories had been allowed to die on the premises, when reanimation equipment was right there. No doubt the question would be raised in the afternoon papers, since any news of the Beller researchers rated a good play.

He was not mistaken. At noon Mart Raymond called; he stared somewhat reproachfully at Harker out of the screen and said, “Some reporters just phoned up, Jim. They saw Barchet’s obit and want to know how come he wasn’t reanimated. What am I supposed to tell them—the truth?”

Harker scowled. “Don’t tell them anything. Let me think. Ah—yes. Tell them Barchet was despondent over personal affairs, and left a memo imploring us not to reanimate him. Naturally, we abide by his last request.”

“Naturally,” Raymond said acidly. “Okay. I’ll tell them. It sounds halfway plausible, anyway.”

The newspapers moved fast. By nightfall the story had been promoted to the front pages, generally headed with something like BELLER MAN CHOOSES DEATH. The editorial pages of the Star-Post’s evening edition had an interesting comment:

NATURAL DEATH OR SUICIDE?

Yesterday Simeon Barchet, an executive of the now-famous Beller Research Laboratories, died suddenly of a heart attack. According to his colleagues at Beller, Mr. Barchet had been in a despondent frame of mind and left instructions that he was not to be reanimated.

The situation exposed a new facet of the already-explosive reanimation situation. Can wilful refusal to undergo reanimation be considered suicide? According to time-honored principles of law, suicide or attempted suicide is an illegal act. In this case, the odd paradox arises of a man already dead committing what can only be termed suicide. Should reanimation be given the cachet of legal approval during the forthcoming Congressional hearings, then it is clear that a testament forbidding reanimation will reach beyond the grave to bind the dead man’s survivors, counsel, and physicians in a conspiracy to abet suicide.

Obviously this is an impossible state of affairs. It demonstrates once again that the staggering Seller Laboratories success, which renders death in many cases merely temporary, will unavoidably bring about a massive revolution in our codes of legal and medical ethics, and indeed a change in our entire manner of life.

As he looked through the heap of newspapers, Marker began to feel that the tide was turning. The hysteria was dying down. Men were realizing that reanimation was no grisly joke, no hoax, but something real that had been developed and which could not be stamped out.

There were relatively few cries for wholesale suppression of the process. A Fundamentalist minister from Kansas had got his name into the papers by demanding immediate destruction of all equipment and plans for reanimation apparatus, but his was an isolated voice.

The tone of the Star-Post editorial seemed to be the tone of the consensus. Men of intelligence were saying, Reanimation exists, for good or evil. Let’s study it for a while and find out what it can do and how it will change society. Let’s not scream, for its suppression, but let’s not unleash it entirely before we know what we’re letting loose.

The most authoritative of the secular anti-reanimation voices had belonged to Clyde Thurrnan, and that voice now was stilled. The act had been one of colossal audacity and thoughtlessness, and even now Harker found it difficult to endure the memory of the noble old warrior’s mindless eyes; but, he had to admit, it had silenced a potent force for suppression.

Perhaps these were times for violence and audacity, Harker thought.

In that case I’m the wrong man for my job. But it’s too late to help that now.

Sunday’s papers continued the general trend toward reasonable consideration of the reanimation case, and also reported no progress in the search for the missing senator. It was learned that the reanimation hearings would begin as scheduled on Monday—not in Washington, though, but in New York. Late Sunday evening a messenger appeared at Harker’s door and handed him a document.

It was a subpoena, requesting him to be present at 10:00 the following morning at the Hotel Manhattan, where the Congressional hearings would begin.

Harker arrived there half an hour early. The hearings were taking place in a meeting-room on the nineteenth floor of the big hotel. Federal law required the presence of the press at Congressional hearings; television cameras were already set up, and at the back of the room Harker saw the four senators who had visited the labs: Brewster, Vorys, Dixon, Westmore. Two American-Conservatives, two Nationa Liberals. The fifth seat had been left vacant, obviously for Thurman; but Thurman would not be likely to take part in the hearings, though only a few men knew that fact with any certainty.

Mart Raymond was there already, wearing not his stained lab smock but a surprisingly natty tweed suit. Vogel had been subpoenaed too, but not Lurie. Next to Raymond sat a plumpish woman Harker had never seen before; she was middle-aged and dressed in an obsolete fashion.

“Jim, I want you to meet someone,” Raymond called to him as soon as Harker entered. He crossed the room to the front row of seats and Raymond said, “This is Mrs. Beller. She’s acting as representative for the Beller Fund since Barchet died.”

“Dreadful, about poor Mr. Barchet,” the woman said, in a highly masculine baritone. “Pleased to meet you, Mr. Harker. I’ve heard so much about you. My late husband was deeply intersted in your career.”

I’m damned sure of that, Harker thought. For as many years as he could remember, the name of Darwin F. Beller had headed the list of contributors to the annual American-Conservative Party campaign fund. He said aloud, “How do you do, Mrs. Beller.”

He looked toward the platform where the senators sat. Brewster looked grim, Vorys peeved; Dixon and Westmore, the Nat-Lib members of the commission, both wore identical uneasy smiles.

Television cameramen seemed to be under foot everywhere, checking camera angles, adjusting mike booms, testing the lighting. A small, harried-looking man with close-cropped hair came scurrying up to him, jabbed a microphone under his nose, and said, “Mr. Harker, would you mind saying a couple of words into this?”

“What do you want me to say?”

“That’s fine, sir. Now you, Mr. Raymond, and then after that I’d like to hear the lady speak.”

It was a voice-test. Someone yelled out, “Harker’s fine! Raymond could stand more resonance!”

“Would you mind getting more chest into your voice, Mr. Raymond?”

“I’ll do my best,” Raymond said.

The man with the microphone scurried away.

Harker watched the time on the big clock above the dais. Ten minutes to ten. The room was slowly filling up, not only with newspapermen. Raymond pointed out a couple of well-known medical men; Harker spotted two lawyers, including one who had issued a ringing denunciation of reanimation a week before.

At ten sharp Senator Westmore rose, smiled apologetically at the video camera, and said, “Good morning, ladies and gentlemen. As acting chairman of the Senate Special Investigating Committee dealing with the problem of the discoveries of the Beller Research Laboratories, I hereby ask for your attention and call this hearing to order.”

The room fell silent. In the hush, the throbbing purr of the official stenographer’s recording machine was clearly audible. After a pause Westmore went on, “We begin this session in the absence of our chairman, Senator Thurman of New York. I’m sure you’ll all join me in the hope that the beloved senator is safe, wherever he is, and that his unusual absence will soon be explained. However, the—shall we say—delicate nature of the Beller discoveries makes it imperative that this Committee elicit facts and present its findings to Congress immediately, and so we are proceeding on schedule despite our chairman’s absence.

“Our purpose is to draw forth information on the subject of reanimation. First I think it is well to question the director of the laboratory which developed the technique, Dr. Martin Raymond.”

Raymond rose, a trifle awkwardly, and as he did so Senator Vorys requested permission to question him. Permission was granted.

Vorys said, in this thin, penetrating voice, “Dr. Raymond, you recognize me, do you not, as a member of the group of United States Senators who visited your laboratories recently?

“I recognize you. You were there.”

“In our presence you applied your reanimation technique to a twelve-year-old boy. Am I correct?”

“You are.”

“The boy was dead?”

“He had drowned the day before.”

“And where is this boy now?”

Raymond said, “Recuperating from the aftereffects of his experience. He’s in good health, but still pretty weak.”

“Ah. Would it be possible for you to bring this boy to a session of this Committee?”

“I don’t believe so, Senator. The boy’s not ready for any travelling yet. And it would violate our policy to present him to the video audience. We try to keep the identity of our patients secret.”

“Why do you do that?”

“To protect them. Reanimation is still in its early stages. The social implications are still unclear.”

“Ah. Would you object if the members of this Committee paid the boy a visit, then, to ascertain the current state of his health?”

“That could be arranged,” Raymond said.

There was a moment of silence. Vorys stared keenly at Raymond and said, “Would you trace briefly for us the history of your laboratory, the nature of your process, and the results you have obtained so far.”

Speaking easily and freely now, Raymond told of the original Seller bequest, the gathering-together of the laboratory staff, the early failures. He outlined a rough sketch of the technique as it was now practiced. “To date we’ve had about seventy successful reanimations,” he finished.

“And how many failures?”

“About ten out of the seventy. Previous to our first successful reanimation we had thirty consecutive failures?”

“I see. And what is the nature of these failures?”

Raymond began to fidget. “Ah—well, we don’t succeed in restoring life.”

“The body remains inanimate?”

“Yes. Most of the time, that is. I mean—”

It was too late. Vorys pounced on the slip gleefully and said, “Most of the time, Dr. Raymond? I don’t quite understand. Does that mean that some of your failures result in actual reanimation, or partial reanimation? Will you make yourself clear?”

Panicky, Raymond glanced at Marker, who shrugged and nodded resignedly. It had to come out eventually, Harker thought.

The squirming Raymond was a pitiful sight under the merciless lights. He said in a hopeless voice, “I guess I ought to be more specific.”

“That would help, Dr. Raymond.”

“Well,” Raymond said, “Counting the boy we reanimated when you were at the labs, Senator, we’ve had 72 reanimations since the first success. No, 73. In 62 of those cases, we’ve had complete success. In four others, it was impossible for us to restore life at all. And in the remaining seven”—now it comes out, Harker thought—“we achieved reanimation with partial success.”

“In what way partial?” Vorys pressed.

Raymond had run out of evasions. He said, “We restored the body to functional activity. We were unable to achieve a similar restoration of the mind, in those seven cases.”

Загрузка...